ResearcherUniversity of Oklahoma Health Sciences CenterNo recent work listed

Hunter Chalfant

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-2781-1116; OpenAlex author ID A5063744288. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2023: 1 paper

Papers 1

Innovative Imaging Techniques Used to Evaluate Borderline-Resectable Pancreatic Adenocarcinoma. Co-author DOI 10.1016/j.jss.2022.10.008 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ajay Jain · 1 shared paper, 2023 · strength 0.18
- Paper Innovative Imaging Techniques Used to Evaluate Borderline-Resectable Pancreatic Adenocarcinoma. DOI 10.1016/j.jss.2022.10.008 ↗
Morgan Bonds · 1 shared paper, 2023 · strength 0.18
- Paper Innovative Imaging Techniques Used to Evaluate Borderline-Resectable Pancreatic Adenocarcinoma. DOI 10.1016/j.jss.2022.10.008 ↗
Isabel S. Dennahy · 1 shared paper, 2023 · strength 0.18
- Paper Innovative Imaging Techniques Used to Evaluate Borderline-Resectable Pancreatic Adenocarcinoma. DOI 10.1016/j.jss.2022.10.008 ↗
Barish H. Edil · 1 shared paper, 2023 · strength 0.18
- Paper Innovative Imaging Techniques Used to Evaluate Borderline-Resectable Pancreatic Adenocarcinoma. DOI 10.1016/j.jss.2022.10.008 ↗
Lacey R. McNally · 1 shared paper, 2023 · strength 0.18
- Paper Innovative Imaging Techniques Used to Evaluate Borderline-Resectable Pancreatic Adenocarcinoma. DOI 10.1016/j.jss.2022.10.008 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.